19 Jan 2022 , 11:54 AM
Lupin Ltd on Wednesday announced its partnership with Shenzhen Foncoo Pharmaceutical Co. Ltd. which reinforces its commitment to bringing high-quality generic and complex generic medicines to patients around the world. This partnership is in arrangement with China and enforces Lupin’s commitment to bring high-quality generic and complex generic medicines to patients around the world.
“Lupin continues to invest in key growth markets. With China’s growing dedication to affordable and accessible healthcare for all, Lupin is dedicated to serving the healthcare needs of the Chinese population by bringing forth high quality generic and complex generic products,” said Dr. Fabrice Egros, President — Growth Markets, Lupin.
He further added, “We are thrilled about our partnership with Foncoo and seek to further explore additional partnership opportunities in China to leverage our global portfolio including complex generics and specialty medicines.”
“Foncoo’s successful experiences on importing registration and marketing of the generic formulations and Lupin’s strong capability of making high-quality medicines make us perfect match to each other and our collaboration will have a bright future most likely. We expect that the successful launch of our first product in China will come smoothly and soon. We will continue to explore further opportunities to work with Lupin for providing more and more high-value and complex medicines to the Chinese physicians and patients,” said General Manager, Mr. Peng Yan, Foncoo.
Lupin enjoys leader position in the cardiovascular, respiratory segments and anti-diabetic, and has a significant presence in the anti-infective, gastro-intestinal (GI), women’s health, and central nervous system (CNS) areas. Lupin is the third-largest pharmaceutical company in the U.S. by prescriptions.
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.